Hence, it is important to perform more studies on miR-34a levels in HPV infection and cervical lesions/cancer and to clarify whether there are other pathways besides the p53-associated pathways, which are able to activate miR-34a expression in HPV-associated lesions. Here, TP53 is linked to cancer.